Brand Name: Cabotib 40
Generic Name: Cabozantinib
Strength: 40 mg
Manufacturer: Glenmark Pharmaceuticals
Dosage Form: Oral Tablets
Packaging: 30 Tablets per Bottle
Therapeutic Category: Oncology / Anticancer Medicine
Country of Origin: India
Supplier & Exporter: BizHQ
Website: www.medicineindiaexport.com
Introduction to Cabotib 40 mg Tablets
Cabotib 40 mg Tablets contain Cabozantinib, a prescription anticancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. Manufactured by Glenmark Pharmaceuticals, Cabotib 40 mg is used in the management of certain advanced cancers under specialist medical supervision.
Cabozantinib works by blocking multiple protein kinases involved in tumor growth, angiogenesis, and cancer progression.
BizHQ is an India-based pharmaceutical export business welcoming international sourcing enquiries for Cabotib 40 mg Tablets from licensed pharmaceutical importers, wholesalers, distributors, hospitals, and authorized healthcare procurement organizations.
We assist international buyers with product information, commercial quotations, packaging details, and pharmaceutical export enquiries, subject to stock availability and applicable regulatory requirements.
Product Specifications
| Product Details | Description |
|---|---|
| Product Name | Cabotib 40 |
| Generic Name | Cabozantinib |
| Strength | 40 mg |
| Manufacturer | Glenmark Pharmaceuticals |
| Country of Origin | India |
| Dosage Form | Oral Tablets |
| Pack Size | 30 Tablets |
| Therapeutic Category | Oncology |
| Drug Classification | Multi-targeted Tyrosine Kinase Inhibitor |
| Prescription Status | Prescription Only |
| MOQ | On Enquiry |
| Export Availability | Subject to Confirmation |
What Is Cabotib 40 mg Used For?
Cabotib 40 mg contains Cabozantinib, which is used in the treatment of certain types of cancer.
Depending on the approved product indication and local prescribing information, cabozantinib tablet formulations may be used for:
1. Advanced Renal Cell Carcinoma (RCC)
Cabozantinib is used in certain patients with advanced kidney cancer, either alone or as part of an approved combination treatment.
2. Hepatocellular Carcinoma (HCC)
Cabozantinib may be prescribed for eligible patients with hepatocellular carcinoma who have previously received specific systemic treatments.
3. Differentiated Thyroid Cancer (DTC)
Certain cabozantinib tablet products are approved for selected patients with locally advanced or metastatic differentiated thyroid cancer following previous treatment.
Important: Indications differ by country and product authorization. Cabotib's specific approved indications must be verified using its local prescribing information. Cabozantinib tablets and capsules are not automatically interchangeable.
How Does Cabotib 40 mg Work?
Cabozantinib inhibits several receptor tyrosine kinases, including MET, VEGFR, AXL, and RET.
These proteins can play important roles in tumor growth, cancer cell survival, and the development of blood vessels supplying tumors.
By inhibiting these signaling pathways, Cabozantinib may help slow cancer progression in appropriately selected patients.
Treatment requires supervision by a qualified oncologist because cabozantinib can cause serious adverse reactions and requires monitoring.
Why Source Cabotib 40 mg from India?
India has an established pharmaceutical manufacturing sector supplying medicines to domestic and international markets.
Established Pharmaceutical Industry
Indian pharmaceutical manufacturers produce a broad range of prescription medicines, including specialized oncology treatments.
Generic Oncology Medicine Sourcing
International buyers may explore Indian pharmaceutical sourcing options where products meet destination-country quality, registration, and import requirements.
Wholesale Procurement Opportunities
Licensed distributors, pharmaceutical wholesalers, hospitals, and institutional buyers may enquire about commercial quantities of Cabotib 40 mg.
International Shipping Coordination
Pharmaceutical exporters may assist with packaging, shipping documentation, and logistics planning, subject to legal requirements and shipment eligibility.
Target Export Countries for Cabotib 40 mg Tablets
BizHQ welcomes enquiries from authorized pharmaceutical buyers in multiple international markets.
Asian Markets
Malaysia, Philippines, Vietnam, Thailand, Singapore, Indonesia, South Korea, Japan, Bangladesh, Nepal, and Sri Lanka.
Middle East Markets
United Arab Emirates, Saudi Arabia, Oman, Qatar, Kuwait, Bahrain, Jordan, and Iraq.
African Markets
South Africa, Kenya, Nigeria, Ghana, Tanzania, Uganda, Zambia, Ethiopia, and Rwanda.
European Markets
United Kingdom, Germany, France, Italy, Spain, Netherlands, Belgium, Poland, and Portugal.
North and South American Markets
United States, Canada, Mexico, Brazil, Chile, Peru, Colombia, and Argentina.
Oceania Markets
Australia and New Zealand.
These are potential enquiry markets. Listing a country does not establish that Cabotib 40 mg is approved, registered, or eligible for import there. Each shipment requires a destination-specific regulatory assessment.
Pharmaceutical Export Documentation
International pharmaceutical transactions may require documentation such as:
Commercial Invoice
Packing List
Certificate of Analysis (COA), where available
Certificate of Origin (COO), when applicable
Manufacturer documentation
Product registration information
Import licenses and permits
Customs and shipping documents
The exact documentation requirements depend on the destination country and transaction.
Storage and Handling
Cabotib 40 mg Tablets should be stored according to the manufacturer's approved labeling.
Pharmaceutical importers and distributors should ensure appropriate environmental conditions, protection against moisture, secure packaging, and batch traceability throughout the supply chain.
Frequently Asked Questions (FAQs)
Q1. What is Cabotib 40 mg?
Cabotib 40 mg is a prescription medicine containing Cabozantinib, a multi-targeted tyrosine kinase inhibitor used in oncology.
Q2. Who manufactures Cabotib 40 mg Tablets?
The pictured Cabotib 40 mg product is branded by Glenmark Pharmaceuticals.
Q3. What is the packaging size of Cabotib 40 mg?
The pictured product contains 30 tablets per bottle.
Q4. Can I enquire about Cabotib 40 mg wholesale supply?
Yes. Licensed pharmaceutical wholesalers, importers, distributors, and institutional buyers can contact BizHQ for sourcing enquiries.
Q5. Is Cabotib 40 mg available for international export?
Potential export arrangements depend on stock availability, applicable export laws, product registration, import authorization, and destination-country regulations.
Q6. What is the minimum order quantity?
Minimum order quantity depends on supplier conditions and available inventory. Contact BizHQ for details.
Q7. Can Cabotib 40 mg be used without a prescription?
No. Cabotib is a prescription oncology medicine requiring qualified medical supervision.
Q8. How can international buyers request a quotation?
Buyers can contact BizHQ with their required quantity, destination country, and relevant pharmaceutical business credentials.
Why Choose BizHQ for Pharmaceutical Sourcing Enquiries?
BizHQ supports international pharmaceutical trade enquiries involving medicines manufactured in India.
Our commercial focus includes:
Oncology medicine sourcing enquiries
Wholesale pharmaceutical procurement
International buyer communication
Product specification and packaging information
Commercial quotation requests
Export documentation coordination, where applicable
Buyers are encouraged to confirm their country's product registration and import requirements before initiating procurement.
Contact BizHQ – Cabotib 40 mg Export Enquiries
Business Name: BizHQ
Website: www.medicineindiaexport.com
Email: sales.medindiaexport@gmail.com
WhatsApp: +91 7218129896
Country: India
